- Home
- EBR vs ILMN Comparison
EBR vs ILMN Comparison
Compare EBR & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBR
- ILMN
- Stock Information
- Founded
- EBR 1962
- ILMN 1998
- Country
- EBR Brazil
- ILMN United States
- Employees
- EBR N/A
- ILMN N/A
- Industry
- EBR Electric Utilities: Central
- ILMN Medical Specialities
- Sector
- EBR Utilities
- ILMN Health Care
- Exchange
- EBR Nasdaq
- ILMN Nasdaq
- Market Cap
- EBR 14.8B
- ILMN 15.9B
- IPO Year
- EBR N/A
- ILMN 2000
- Fundamental
- Price
- EBR $7.23
- ILMN $71.16
- Analyst Decision
- EBR
- ILMN Buy
- Analyst Count
- EBR 0
- ILMN 18
- Target Price
- EBR N/A
- ILMN $139.50
- AVG Volume (30 Days)
- EBR 1.4M
- ILMN 2.6M
- Earning Date
- EBR 05-10-2025
- ILMN 05-08-2025
- Dividend Yield
- EBR 3.86%
- ILMN N/A
- EPS Growth
- EBR 130.56
- ILMN N/A
- EPS
- EBR 0.74
- ILMN N/A
- Revenue
- EBR $6,496,718,152.00
- ILMN $4,372,000,000.00
- Revenue This Year
- EBR $3.85
- ILMN $0.09
- Revenue Next Year
- EBR $10.26
- ILMN $4.71
- P/E Ratio
- EBR $7.50
- ILMN N/A
- Revenue Growth
- EBR 8.13
- ILMN N/A
- 52 Week Low
- EBR $5.45
- ILMN $68.70
- 52 Week High
- EBR $7.93
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- EBR 56.38
- ILMN 34.13
- Support Level
- EBR $7.00
- ILMN $68.70
- Resistance Level
- EBR $7.22
- ILMN $76.16
- Average True Range (ATR)
- EBR 0.20
- ILMN 4.18
- MACD
- EBR -0.02
- ILMN 0.38
- Stochastic Oscillator
- EBR 71.05
- ILMN 17.50
About EBR Centrais Electricas Brasileiras S A (Each representing one Common Share)
Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company's cash management, the management of the compulsory loan, and the management of business in SPEs, and others.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.